Sign in
WithdrawnPhase 4

The Effect of a Methylprednisolone Taper on Outcomes Following Total Knee Arthroplasty

Key facts

Who runs it
F. Johannes Plate
Where
Monroeville and Pittsburgh, United StatesSee the 2 sites
Trial code
Status
Withdrawn
Phase
Phase 4
Started
1 Nov 2025
Expected to end
1 Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Methylprednisolone 4 milligram Tab
  • Dexamethasone injection
Record updated
5 February 2026
Why it stopped
withdrawn

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients indicated for primary total knee arthroplasty
  • Access to computer or smartphone for completion of REDCap surveys

Who cannot take part

  • Patients less than 18 years of age, patients unable to consent, known diabetic patients and those with an HgbA1c >6.5 preoperatively, patients who are on chronic steroid treatments, patients with chronic pain on opioid management, patients with allergies to steroids, patients with a history of peptic ulcer disease, patients with a history of heart failure and patients with a history of renal and/or hepatic failure will be excluded. Those that are immunosuppressed as well as pregnant and/or lactating will also be excluded

Where in United States

  • UPMC EastMonroeville, United States
  • UPMC-Shadyside HospitalPittsburgh, United States

About the trial

What the trial wants to find out

Pain control and early range of motion following total knee arthroplasty are essential for patient satisfaction. Intraoperative steroids (dexamethasone) have been shown to have a significant effect in controlling acute pain following total knee arthroplasty. This study aims to evaluate the effect of a post-operative steroid (methylprednisolone) taper in improving functional and patient-reported outcomes following total knee arthroplasty. A taper means taking a high dose of a medication followed by taking lower doses and each following day until the medication is stopped.

The 2 groups in the trial

  • Intraoperative and Post-operative steroidTreatment being tested

    Patients in this groups will receive intraoperative intravenous dexamethasone as well as a 6-day post-operative methylprednisolone taper

    Treatment: Methylprednisolone 4 milligram Tab and Dexamethasone injection

  • Intraoperative SteroidExisting treatment, for comparison

    Patients randomized to this group will only receive intraoperative intravenous dexamethasone

    Treatment: Dexamethasone injection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 February 2026